ATE353887T1 - Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze - Google Patents
Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salzeInfo
- Publication number
- ATE353887T1 ATE353887T1 AT03762106T AT03762106T ATE353887T1 AT E353887 T1 ATE353887 T1 AT E353887T1 AT 03762106 T AT03762106 T AT 03762106T AT 03762106 T AT03762106 T AT 03762106T AT E353887 T1 ATE353887 T1 AT E353887T1
- Authority
- AT
- Austria
- Prior art keywords
- esomeprazole
- amorphene
- salts
- optically
- compounds including
- Prior art date
Links
- SUBDBMMJDZJVOS-DEOSSOPVSA-N esomeprazole Chemical compound C([S@](=O)C1=NC2=CC=C(C=C2N1)OC)C1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-DEOSSOPVSA-N 0.000 title abstract 2
- 229960004770 esomeprazole Drugs 0.000 title abstract 2
- QMAYBMKBYCGXDH-KFWWJZLASA-N (1r,4as,8ar)-4,7-dimethyl-1-propan-2-yl-1,2,4a,5,6,8a-hexahydronaphthalene Chemical compound C1CC(C)=C[C@H]2[C@@H](C(C)C)CC=C(C)[C@H]21 QMAYBMKBYCGXDH-KFWWJZLASA-N 0.000 title 1
- -1 SULFOXIDE COMPOUNDS Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical class N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 abstract 1
- 208000012895 Gastric disease Diseases 0.000 abstract 1
- 229960000381 omeprazole Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003462 sulfoxides Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN489MA2002 | 2002-06-27 | ||
| IN493MA2002 | 2002-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE353887T1 true ATE353887T1 (de) | 2007-03-15 |
Family
ID=34276871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03762106T ATE353887T1 (de) | 2002-06-27 | 2003-06-27 | Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN100378093C (de) |
| AT (1) | ATE353887T1 (de) |
| AU (1) | AU2003247729B2 (de) |
| CA (1) | CA2491118A1 (de) |
| DE (1) | DE60311809T2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2143722A1 (de) * | 2008-07-09 | 2010-01-13 | Lek Pharmaceuticals D.D. | Verfahren zur Herstellung von Esomeprazol-Natrium von hoher chemischer Reinheit und neue Formen von Esomeprazol-Natrium |
| CN103145694B (zh) * | 2011-12-06 | 2016-01-20 | 重庆煜澍丰医药有限公司 | 埃索美拉唑钠盐的晶体r及其制备方法和用途 |
| CN102993184A (zh) * | 2013-01-08 | 2013-03-27 | 湖南方盛制药股份有限公司 | 一种埃索美拉唑及其镁盐三水合物的制备方法 |
| CN103664887B (zh) * | 2013-12-18 | 2015-09-16 | 成都医路康医学技术服务有限公司 | 埃索美拉唑钠的制备方法 |
| CN104530003A (zh) * | 2014-06-10 | 2015-04-22 | 广东东阳光药业有限公司 | 吡啶甲基亚磺酰基-1h-苯并咪唑类化合物的盐的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE510666C2 (sv) * | 1996-12-20 | 1999-06-14 | Astra Ab | Nya Kristallmodifikationer |
| SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
| US6369087B1 (en) * | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
-
2003
- 2003-06-27 AT AT03762106T patent/ATE353887T1/de not_active IP Right Cessation
- 2003-06-27 CA CA002491118A patent/CA2491118A1/en not_active Abandoned
- 2003-06-27 DE DE60311809T patent/DE60311809T2/de not_active Expired - Lifetime
- 2003-06-27 CN CNB038151529A patent/CN100378093C/zh not_active Expired - Fee Related
- 2003-06-27 AU AU2003247729A patent/AU2003247729B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN100378093C (zh) | 2008-04-02 |
| DE60311809T2 (de) | 2007-11-22 |
| CN1665805A (zh) | 2005-09-07 |
| AU2003247729B2 (en) | 2009-10-08 |
| CA2491118A1 (en) | 2004-01-08 |
| AU2003247729A1 (en) | 2004-01-19 |
| DE60311809D1 (de) | 2007-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004002982A3 (en) | A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof | |
| BR0205722A (pt) | Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor | |
| DE602004020263D1 (de) | Amino-substituierte diaryläa,dücyclohepten- analoga als muscarinische agonisten und verfahren zur behandlung von neuropsychiatrischen erkrankungen | |
| MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
| YU71901A (sh) | NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA | |
| BRPI0415288A (pt) | composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto | |
| BRPI0416283A (pt) | compostos, processo para a fabricação de compostos, composição farmacêutica, método para o tratamento e/ou prevenção de doenças que são moduladas por agonistas de ppar(delta) e/ou ppar(alfa) e uso destes compostos | |
| DE60216830D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen | |
| ATE373474T1 (de) | Substituierte 2-aminotetraline zur behandlung von depressionen | |
| BR0309345A (pt) | Composto ou sais farmaceuticamente aceitáveis do mesmo, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou de distúrbios de dano intelectual, e de jetlag, interrupção do hábito de fumar, dependência de nicotina, ânsias, dor e colite ulcerativa | |
| DE602004029580D1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
| EA200401365A1 (ru) | Способы лечения илеуса | |
| YU35503A (sh) | Nove kompozicije lekova bazirane na solima tiotropijuma i solima salmeterola | |
| ATE450514T1 (de) | Piperazinylalkylpyrazol-derivate zur verwendung als selektive calciumkanalblocker des t-typs und verfahren zu ihrer herstellung | |
| BR0315574A (pt) | Forma amorfa de esomeprazol, composição farmacêutica contendo o mesmo e processo para sua preparação | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| WO2003087049A3 (de) | Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum | |
| DE602004002394D1 (de) | (3-ä3-'(2,4-BIS-TRIFLUORMETHYL-BENZYL)-(5-ETHYL-PYRIMIDIN-2-YL)-AMINOÜ-PROPOXYü-PHENYL)-ESSIGSÄURE UND VERWANDTE VERBINDUNGEN ALS MODULATOREN VON PPARS UND VERFAHREN ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN | |
| WO2004087700A8 (fr) | Derives du benzenesulfonamide, leur procede de preparation et leur utilisation de la douleur | |
| EA200602016A1 (ru) | ПОРОШКОВЫЕ КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ | |
| ATE353887T1 (de) | Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze | |
| EA200700637A1 (ru) | Соли донепезила, подходящие для получения фармацевтических композиций | |
| ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| BRPI0417117A (pt) | temozolomida cristalizada, processo de preparação de temozolomida cristalizada, composição farmacêutica, método de produção de medicamento contendo temozolomida e método de tratamento de uma condição médica para a qual a termozolomida é benéfica | |
| ATE528301T1 (de) | Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |